| pubmed-article:2777585 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2777585 | lifeskim:mentions | umls-concept:C0085403 | lld:lifeskim |
| pubmed-article:2777585 | lifeskim:mentions | umls-concept:C0348080 | lld:lifeskim |
| pubmed-article:2777585 | lifeskim:mentions | umls-concept:C0283030 | lld:lifeskim |
| pubmed-article:2777585 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:2777585 | pubmed:dateCreated | 1989-10-17 | lld:pubmed |
| pubmed-article:2777585 | pubmed:abstractText | Different factors that give the maximum iodination of proteins by iodogen method have been evaluated. The quantity of iodogen was varied from 2 to 20 micrograms; pH from 3 to 9; the quantity of bovine serum albumin (BSA) from 25 micrograms to 2 mg; the 131I activity from 200 microCi to 5 mCi and the reaction time from 2 to 30 min. The maximum iodination of proteins is achieved with iodogen-to-iodide molar ratio of 100-200 and iodogen-to-protein molar ratio of 1-2 at pH 6-8 for 10-15 min at room temperature. | lld:pubmed |
| pubmed-article:2777585 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2777585 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2777585 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2777585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2777585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2777585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2777585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2777585 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2777585 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2777585 | pubmed:issn | 0883-2897 | lld:pubmed |
| pubmed-article:2777585 | pubmed:author | pubmed-author:SahaG BGB | lld:pubmed |
| pubmed-article:2777585 | pubmed:author | pubmed-author:HOR WRW | lld:pubmed |
| pubmed-article:2777585 | pubmed:author | pubmed-author:WhittenJJ | lld:pubmed |
| pubmed-article:2777585 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2777585 | pubmed:volume | 16 | lld:pubmed |
| pubmed-article:2777585 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2777585 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2777585 | pubmed:pagination | 431-3 | lld:pubmed |
| pubmed-article:2777585 | pubmed:dateRevised | 2008-2-21 | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:meshHeading | pubmed-meshheading:2777585-... | lld:pubmed |
| pubmed-article:2777585 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2777585 | pubmed:articleTitle | Conditions of radioiodination with iodogen as oxidizing agent. | lld:pubmed |
| pubmed-article:2777585 | pubmed:affiliation | Department of Nuclear Medicine, Cleveland Clinic Foundation, OH 44195-5074. | lld:pubmed |
| pubmed-article:2777585 | pubmed:publicationType | Journal Article | lld:pubmed |
